Study outcomes
SECONDARY
We report the predefined, secondary endpoints of the MIRAD trial: change in left ventricular function by echocardiography (LVEF, EDV, ESV, e’, GLS), with additional focus on diastolic function (E/e’, E/A, left atrial volume) and LVMi.